ARTICLE | Distillery Therapeutics
Neurology
August 23, 2018 3:48 PM UTC
In vitro, cell culture and mouse studies identified an inhibitor of the SOD1-DERL1 interaction that could help treat familial ALS caused by SOD1 mutations. Screening of a small molecule library, chemi...
BCIQ Company Profiles
BCIQ Target Profiles